Table 1 The OSMD-based nanoplatforms for NIR photodynamic and photothermal co-therapy
From: Near-infrared photodynamic and photothermal co-therapy based on organic small molecular dyes
Therapeutic method | Nanoplatform | Size | NIR wavelength | Application | References | |
|---|---|---|---|---|---|---|
PDT/PTT combination therapy | Cyanine | AuNR/ICG vesicle | 238.46 nm | 785 nm | PC3 cells | [125] |
ICG-PEI-HAuNs | 122.50 nm | 880 nm | SKOV3 cells | [126] | ||
AuNR@MSN-ICG-RLA/CS(DMA)-PEG | 78.50 × 37.20 nm | 808 nm | MCF-7 cells | [127] | ||
TNYL-ICG-HAuNS | 70 nm | 880 nm | SKOV3 cells | [135] | ||
FAL-ICG-HAuNS | 151 nm | 890 nm | CT-26 cells | [136] | ||
Fe3O4@PDA@CaCO3/ICG | 17.40 nm | 700–900 nm | 4T1 cells | [139] | ||
Fe-PDAP/GOx/ICG | 48.90 nm | 720–786 nm | MDA-MB-231 cells | [140] | ||
Cu9S5@mSiO2-ICG@PEG-LA | 50 nm | 808 nm | HepG2 cells | [141] | ||
HA-Ti@GO/ICG | – | 700–900 nm | 4T1 cells | [142] | ||
NGO-808 | 20–40 nm | 808 nm | A549, Lewis tumor cells | [149] | ||
ICG/rPAA@SWCNTs | 420 nm | 808 nm | Hela cells | [158] | ||
COF@probe | – | 808 nm | 3T3 cells | [159] | ||
COF@ICG@OVA | 100 nm | 650 nm, 808 nm | H22 cells | [160] | ||
UCNPs@PDA-ICG | 40 nm | 808 nm | H22 cells | [161] | ||
HA-PB/ICG | 290 nm | 808 nm | 4T1 cells | [163] | ||
HA-PEG-CyI | 112.50 nm | 808 nm | 4T1 cells | [164] | ||
M@PPI-siRNA | 190.50 nm | 808 nm | SCC-25, B16 cells | [165] | ||
iRGD-rHDL/ICG | 86.70 nm | 780–800 nm | 4T1 cells | [167] | ||
Porpyrin | P-4 | 46 nm | 714 nm | Hela cells | [170] | |
AuNR@SiO2-TCPP | 190 nm | 660 nm, 808 nm | A549 cells | [175] | ||
PF6-Au | 60–100 nm | 400–800 nm | A549 cells | [177] | ||
Pp4N/GNR | 50 nm | 660 nm, 808 nm | 3T3-L1, 293 T cells | [201] | ||
GO-C60 | 100–400 nm | 650, 808 nm | Hela cells | [202] | ||
VONc-COF-Por | 140 nm | 808 nm | MCF-7 | [204] | ||
TPAPor | 80 nm | 690 nm | Hela cells | [209] | ||
PB@PCN@MEM | 110–140 nm | 660, 808 nm | CT26 cells | [210] | ||
Rhodamine | PSBTBT-Ce6@Rhod | 149 nm | 675 nm | MCF-7 cells | [215] | |
Squarine | BSA-Cy7-SQ/GM | 300 nm | 808 nm | HepG2, HL7702 cells | [219] | |
BODIPY | BDPTPA | 40–160 nm | 808 nm | 143B cells | [223] | |
FMAB NPs | 68.10 nm | 775 nm | Hela cells | [225] | ||
MTAB NPs | 155 nm | 808 nm | 4T1 cells | [226] | ||
Imaging-guided phototherapy | Photoacoustic imaging | COF-366 | 100 nm | 635 nm | 4T1 cells | [238] |
Fluorescence imaging | Cypate, Cy7, CyI | – | 804 nm, 776 nm, 750 nm | HepG2 cells | [244] | |
AgSiO2-PpIX | 125 nm | 630 nm, 698 nm | – | [245] | ||
AuNRs@SiO2-IR795 | 19.40 nm-82.50 nm | 795 nm, 812 nm | U251MG, HepG2 cells | [247] | ||
Magnetic resonance imaging | FeS2@C-ICG-PEG | 200 nm | 808 nm | HepG2 cells | [253] | |
GNRs@BPP-Gd | 80 nm | 808 nm | 4T1 cells | [256] | ||
Multimodal imaging | ICG-PtMGs@HGd | 92.50 nm | 800 nm | 4T1 cells | [262] | |
HSA-ICG | 75 nm | 671 nm | 4T1 cells | [263] | ||
ICG-Ag@PANI | 115.70 nm | 808 nm | Hela cells | [264] | ||
PMATIB/PEI/Au nanoshell/HA | 187 nm | 808 nm | MCF-7 cells | [265] | ||
FCCP NPs | 100 nm | 635 nm, 980 nm | A549 cells | [271] | ||
Synergistic chemotherapy and phototherapy | Synergistic chemo/PDT/PTT | cRGD@TAT-DINPs | 51.18 nm | 808 nm | MDA-MB-231, A549 cells | [300] |
DOX/ICG@biotin-PEG-AuNC-PCM | 109.10 nm | 800 nm | MCF-7 cells | [301] | ||
Imaging-assisted tri-modal therapy | DZSM NPs | 296.90 nm | 638 nm, 808 nm | 4T1 cells | [275] | |
HMPB@PEI/ICG/DOX | 310.10 nm | 808 nm | 4T1 cells | [298] | ||